Newmont Announces Second Quarter 2022 Earnings Call

Newmont Corporation (NYSE: NEM, TSX: NGT) today announced it will report second quarter 2022 operations and financial results before the market opens on Monday, July 25, 2022, and will hold a conference call at 10 a.m. Eastern Time (8:00 a.m. Mountain Time) the same day. The earnings call will also be carried on the Company's website.

Conference Call Details

Dial-In Number

844.200.6205

Intl. Dial-In Number

929.526.1599

Dial-in Access Code

408771

Conference Name

Newmont

Replay Number

866.813.9403

Intl. Replay Number

44.204.525.0658

Replay Access Code

870232

Webcast Details
Title: Newmont Second Quarter 2022 Earnings Conference Call
URL: https://events.q4inc.com/attendee/715196742

The second quarter 2022 results will be available before the market opens on Monday, July 25, 2022, on the "Investor Relations" section of the Company's website, www.newmont.com . Additionally, the conference call will be archived for a limited time on the Company's website.

About Newmont

Newmont is the world's leading gold company and a producer of copper, silver, zinc and lead. The Company's world-class portfolio of assets, prospects and talent is anchored in favorable mining jurisdictions in North America, South America, Australia and Africa. Newmont is the only gold producer listed in the S&P 500 Index and is widely recognized for its principled environmental, social and governance practices. The Company is an industry leader in value creation, supported by robust safety standards, superior execution and technical expertise. Newmont was founded in 1921 and has been publicly traded since 1925.

Media Contact
Courtney Boone
303.837.5159
courtney.boone@newmont.com

Investor Contact
Daniel Horton
303.837.5468
daniel.horton@newmont.com

News Provided by Business Wire via QuoteMedia

NGT:CA
Marvel Biosciences

Marvel Biosciences Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

The Conversation (0)
Marvel Biosciences

Marvel Biosciences

Developing a human-trial-ready pan-spectrum treatment for autism and other neurological disorders

Developing a human-trial-ready pan-spectrum treatment for autism and other neurological disorders Keep Reading...
Craig Hemke, gold and silver bars.

Craig Hemke: Gold, Silver — Stack on Weakness, "Ultimate Game Changer" Ahead

Craig Hemke, publisher of TFMetalsReport.com, shares his perspective on recent declines in gold and silver, saying that while prices can still go lower, ultimately the math will work out in favor of precious metals and send them to much higher levels. "Gold's just gold. It just sits there.... Keep Reading...
Tavi Costa: Gold Price Takes a Hit — 3 Reasons Why, What's Next

Tavi Costa: Gold Price Takes a Hit — 3 Reasons Why, What's Next

Tavi Costa, CEO of Azuria Capital, weighs in on recent price declines in gold and silver, emphasizing that bottoming is a process that won't happen immediately. In his view, that setup makes the metals more appealing than copper, which has held onto its gains. "I think that the catch-up trade... Keep Reading...
Dana Samuelson, silver bars.

Dana Samuelson: Gold, Silver Prices Drop — Next Support Levels to Watch

Last week silver and gold fell below US$50 per ounce and US$4,000 per ounce, respectively, and Dana Samuelson president of American Gold Exchange, believes the bottom may not yet be in. Speaking a day before those declines, he said lower prices are an economic signal to watch. Don't forget to... Keep Reading...
Prince Silver CEO Derek Iwanaka.

Prince Silver: Maiden Resource Estimate in 2027, Manganese Upside

In an interview with the Investing News Network at the New Orleans Investment Conference, Prince Silver (CSE:PRNC,OTCQX:PRNCF) CEO Derek Iwanaka said the company is targeting a maiden resource estimate for its flagship Prince silver project in Nevada, scheduled for early 2027. He also discussed... Keep Reading...
US flag over gold bars, red descending line and green stock market numbers.

Peter Schiff: Gold’s Slide Rests on Bet the Fed Can’t Deliver

The gold price fell to a one year low on Friday (October 30) as a drop in tech stocks pressured precious metals. According to Reuters, falling tech stocks may have prompted investors to sell gold to cover losses elsewhere in the market. Commerzbank (ETR:CBK) analysts suggested precious metals... Keep Reading...
Canadian Maple Leaf gold coin floating over stacked gold bars with glowing red lights.

Top 5 Junior Gold Mining Stocks on the TSXV in 2026

Junior gold stocks are seeing heightened interest in 2026 despite volatility in the gold price, which reached a new record high of nearly US$5,600 per ounce during the first quarter.The gold price may have fallen to the US$4,000 level in the second and third quarters, but plenty of upside... Keep Reading...
Marvel Biosciences

Marvel Biosciences Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

Interactive Chart

Latest Press Releases

Related News